Hi all,
I have held for a while now and hold both heads and oppies and conceed that I have been a little frustrated like many of the holders, but one of the big reasons that I have invested long term in this company is Tripeptofen. I come from a medical background in pre hospital care and one of the greatest problems facing medicine in general is the control of pain. There are limited choices in the relief of chronic pain due to inflamation with no new breakthoughs for many years, so if Tripeptofen does what has been reported (no evidence to suggest otherwise) it really has a huge ready market to move into.
So as we are talking horses, I am hopeful that the launch of Thermalife gets us through the next 6 months with the at least a price for the conversion of the oppies. This will then set up what I believe is the main race and possibly the big winner, Tripeptofen.
Like horseracing, it could all be a big punt, but I'd like to think it's an educated one.
I also appreciate the comment and opinion from all on this forum as it is the catalyst for further reserch, so all feedback on this point is appreciated.
Cheers,
Cam
Add to My Watchlist
What is My Watchlist?